General MedicationsORALGeneric
FENTANYL
FENTANYL CITRATE
Standard Dose
EQ 0.1MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview FENTANYL is listed in Drugs@FDA under application 020195 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TROCHE/LOZENGE;ORAL - EQ 0.1MG BASE Sponsor CEPHALON Submission history Latest submission status date: 2000-09-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview FENTANYL is listed in Drugs@FDA under application 020195 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TROCHE/LOZENGE;ORAL - EQ 0.1MG BASE Sponsor CEPHALON Submission history Latest submission status date: 2000-09-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.